Developer docs
API playgroundTry for free, no card

Search company profiles

NOCD

Full company profile

uuid0000ic2

Namestring
NOCD
Legal namestring
NOCD Inc.
Websiteurl
treatmyocd.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

NOCD (NOCD Inc.) is a Chicago-based telehealth provider specializing in the treatment of obsessive-compulsive disorder, operating as the world's largest dedicated OCD treatment platform. The company delivers Exposure and Response Prevention (ERP) therapy — the evidence-based first-line treatment for OCD — via live, face-to-face video sessions with specialty-trained therapists licensed across all 50 US states, Canada, the UK, and Australia. The core product suite consists of NOCD Therapy (live video ERP sessions), the NOCD App (between-session therapist messaging, self-directed ERP tools, and a peer community of approximately 1 million members), the Intensive Treatment Program (a 3-6 week virtual intensive outpatient program combining daily group and individual ERP and CBT), and NOCD Academy (free continuing education courses for healthcare providers). All therapists complete graduate-level ERP training supervised by the company's clinical leadership team, and outcomes are validated by the largest peer-reviewed studies of OCD treatment to date (3,552 adults; 2,173 children/adolescents), showing a 43.4% mean symptom reduction in under 12 weeks.

NOCD's business model is primarily insurance-billed specialty telehealth. Approximately 137 million commercial lives are covered through partnerships with 70+ health plans including Kaiser Permanente, Aetna, Cigna, BCBS, and United/Optum, enabling patients to access therapy via standard copays. Out-of-pocket payment options, including interest-free payment plans, are offered for the cash-pay Intensive Treatment Program ($7,400 for the first three weeks). The go-to-market combines direct-to-consumer digital acquisition (organic social, YouTube, TikTok, SEO-driven content) with structured provider referral channels and payer-driven in-network access. Customers are individuals with OCD aged 5 and older, including adults and children, addressing a documented 14-17 year average delay in diagnosis and a 70% misdiagnosis rate in traditional care.

In early 2025, NOCD achieved its first month of positive EBITDA and acquired Rebound Health, a Prolonged Exposure-based PTSD treatment platform. Both brands were restructured under a newly created parent company called Noto, described as an AI-enabled platform designed to scale specialty mental health care. NOCD has raised approximately $84 million since 2018 from investors including F-Prime Capital (Series B lead), 7wireVentures, Cigna Ventures, Kaiser Permanente Ventures, Eight Roads Ventures, Health Enterprise Partners, and Longitude Capital, reaching a valuation of nearly $270 million in 2024.

Short descriptiontext

NOCD is the world's largest dedicated telehealth provider of OCD treatment, delivering evidence-based ERP therapy via live video to patients across all 50 US states, Canada, the UK, and Australia, with revenue intermediated through 70+ insurance plans covering 137 million commercial lives.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
OCD telehealth therapy, behavioral health platform, ERP therapy services, online mental health, exposure response prevention
Industry2 codes
PRIMARYHLALAEAJ
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAFACAJ
Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP)
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Outpatient Mental Health and Substance Abuse Centers62142
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Misc Health & Allied Services, Nec8090
Product category
OCD Telehealth Therapy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Insurance-Covered Telehealth Therapy
TypeSubscription Recurring
Description

NOCD bills insurance plans directly for therapy sessions. The company accepts 70+ health plans including major insurers like Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield. Members pay copays as determined by their insurance coverage.

treatmyocd.com
2Out-of-Pocket / Cash Pay
TypeOne Time License
Description

For patients without adequate insurance coverage or seeking services not covered by insurance (such as the Intensive Treatment Program), NOCD offers out-of-pocket payment options with interest-free payment plans available.

treatmyocd.com
3Intensive Treatment Program
TypeOne Time License
Description

The Intensive Treatment Program costs $7,400 for the first three weeks, with weekly billing continuing for the remainder of the six-week program. An admission assessment costs $240 and is billed separately.

treatmyocd.com
Marketing channels12 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Standard Insurance-Covered ERP Therapy
ModelSubscriptionBilling cadenceMonthly
Notes

Covered by 70+ insurance plans including Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield. Patients pay applicable copays as determined by their insurance plan.

treatmyocd.com
2Intensive Treatment Program - First 3 Weeks
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$7,400 for the first three weeks of the 3-6 week Intensive Treatment Program, which includes daily group and individual therapy using ERP and CBT. Admission assessment is $240, billed separately.

treatmyocd.com
3Intensive Treatment Program - Weeks 4-6
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Weekly billing continues for weeks 4-6 of the Intensive Treatment Program based on clinical need. Payment plans are available.

treatmyocd.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Rebound Health
Description

Trauma recovery platform using Prolonged Exposure principles for PTSD treatment, operating as the second brand under Noto parent company.

linkedin.com
+1 more record
Core offering1 text field

NOCD operates an online behavioral health treatment platform that delivers specialized ERP (Exposure and Response Prevention) therapy for OCD via live, face-to-face video teletherapy sessions with licensed therapists trained in OCD treatment. The core offering is NOCD Therapy, consisting of twice-weekly 60-minute remote ERP video sessions for three weeks followed by once-weekly 30-minute check-ins, supported by 24/7 mobile app access including therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. NOCD also offers a 3-6 week virtual Intensive Treatment Program for severe cases priced at $7,400 for the first three weeks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 12 values shown
  • 43.4% mean reduction in OCD symptoms
+11 more records
Product overview1 text field

NOCD operates a telehealth platform centered on OCD treatment, combining live video ERP therapy with a mobile app for between-session support. The core offerings include NOCD Therapy (live video sessions with specialized therapists), the NOCD App (support tools, ERP exercises, and peer community), NOCD Academy (continuing education for providers), and an Intensive Treatment Program (virtual IOP for severe cases). In March 2025, NOCD acquired Rebound Health and created parent company Noto to expand into PTSD treatment and broader behavioral health conditions.

Product and service2 records
1NOCD Therapy
CategoryOCD Telehealth Therapy
Description

NOCD Therapy is a telehealth OCD treatment service delivering live, face-to-face video ERP (Exposure and Response Prevention) therapy sessions with specialty-trained licensed therapists. The standard treatment protocol includes twice-weekly 60-minute remote ERP video sessions for three weeks, followed by once-weekly 30-minute video check-in sessions, supported by 24/7 mobile app access to therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. Therapy is covered by 70+ health plans including Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield, with patients paying applicable copays. For uninsured or underinsured patients, out-of-pocket payment options with interest-free payment plans are available. The service targets individuals with OCD (adults and children ages 5+) seeking evidence-based specialty care.

2Intensive Treatment Program
CategoryVirtual Intensive Outpatient Program
Description

The Intensive Treatment Program is a 3-6 week virtual intensive outpatient program (IOP) that combines daily group and individual therapy using ERP and CBT for adults with severe OCD who need more immersive support than standard weekly therapy. The program is priced at $7,400 for the first three weeks, with weekly billing continuing for the remainder of the 3-6 week program based on clinical need. An admission assessment costs $240 and is billed separately. The Intensive Treatment Program can lead to up to 47% symptom reduction.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-27
Description

NOCD acquired Rebound Health, a trauma recovery platform using Prolonged Exposure principles for PTSD treatment. Rebound operates as the second brand under Noto, NOCD's AI-enabled parent platform. The acquisition expanded NOCD into PTSD treatment and added over 100 PE-trained specialists to its network.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Kaiser Permanente is a key insurance partner, with NOCD accepting Kaiser plans including Northern and Southern California regions. Kaiser Permanente Ventures also invested in NOCD.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Aetna is a major in-network insurance partner, with NOCD accepting Aetna plans across its network of therapists.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Cigna is an in-network insurance partner for NOCD therapy services, with Cigna Ventures also providing investment.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Blue Cross Blue Shield (BCBS) is an in-network insurance partner across multiple state plans including Illinois, Rhode Island, Massachusetts, Michigan, and Virginia.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

United Healthcare and Optum are in-network insurance partners providing coverage for NOCD therapy services.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Telehealth mental health platform providing evidence-based therapy and medication management for depression, anxiety, and related conditions. Direct peer in virtual specialty behavioral health delivery with similar insurance-billed model and outcomes-focused positioning.

TypeBroad incumbent
Description

Public online therapy platform offering text/video sessions with licensed therapists across mental health conditions. Competes for the same insured patient population and payer contracts but serves a much broader condition set with less specialization.

TypeBroad incumbent
Description

Largest consumer online therapy marketplace (owned by Teladoc). Competes broadly in virtual therapy delivery, including for OCD patients, though with a generalist therapist network rather than OCD specialization.

TypeDirect peer
Description

Subscription-based telehealth platform focused on anxiety, depression, ADHD, and related conditions, with combined therapy and medication management. Direct competitor in insurance-billed virtual mental health for similar patient demographics.

TypeEmerging player
Description

Employer-sponsored mental health benefits platform with personalized care routing across therapy, coaching, and medication. Competes for the same B2B payer channel and increasingly offers specialty care pathways that could include OCD-specific programs.

TypeBroad incumbent
Description

Enterprise mental health benefits provider serving large employers with a blended in-person and virtual provider network. Competes for payer and employer contracts and offers specialty care routing, including for anxiety and OCD.

TypeEmerging player
Description

Insurance-network and billing platform that helps therapists go in-network with major payers. Functions as both an enabler for NOCD's therapist network and a potential competitor building its own patient-facing therapy marketplace.

TypeEmerging player
Description

Therapist network platform providing insurance billing, credentialing, and referrals. Comparable in building a scaled, insurance-friendly therapist network with similar payer relationships, though with a broader condition focus than NOCD.

TypeEmerging player
Description

Therapy platform operating hybrid in-person and virtual clinics with a matched-care model emphasizing therapist-client fit. Competes for in-network insured patients seeking specialized therapy, including anxiety and OCD.

TypeDirect peer
Description

Psychiatry-focused telehealth platform offering in-network medication management and therapy for conditions including anxiety, OCD, and PTSD. Direct peer in specialty virtual psychiatry with similar insurance-billed model and clinical-outcome orientation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NOCD

OCD Telehealth Therapytreatmyocd.com

NOCD is the world's largest dedicated telehealth provider of OCD treatment, delivering evidence-based ERP therapy via live video to patients across all 50 US states, Canada, the UK, and Australia, with revenue intermediated through 70+ insurance plans covering 137 million commercial lives.

What NOCD does

NOCD (NOCD Inc.) is a Chicago-based telehealth provider specializing in the treatment of obsessive-compulsive disorder, operating as the world's largest dedicated OCD treatment platform. The company delivers Exposure and Response Prevention (ERP) therapy — the evidence-based first-line treatment for OCD — via live, face-to-face video sessions with specialty-trained therapists licensed across all 50 US states, Canada, the UK, and Australia. The core product suite consists of NOCD Therapy (live video ERP sessions), the NOCD App (between-session therapist messaging, self-directed ERP tools, and a peer community of approximately 1 million members), the Intensive Treatment Program (a 3-6 week virtual intensive outpatient program combining daily group and individual ERP and CBT), and NOCD Academy (free continuing education courses for healthcare providers). All therapists complete graduate-level ERP training supervised by the company's clinical leadership team, and outcomes are validated by the largest peer-reviewed studies of OCD treatment to date (3,552 adults; 2,173 children/adolescents), showing a 43.4% mean symptom reduction in under 12 weeks.

NOCD's business model is primarily insurance-billed specialty telehealth. Approximately 137 million commercial lives are covered through partnerships with 70+ health plans including Kaiser Permanente, Aetna, Cigna, BCBS, and United/Optum, enabling patients to access therapy via standard copays. Out-of-pocket payment options, including interest-free payment plans, are offered for the cash-pay Intensive Treatment Program ($7,400 for the first three weeks). The go-to-market combines direct-to-consumer digital acquisition (organic social, YouTube, TikTok, SEO-driven content) with structured provider referral channels and payer-driven in-network access. Customers are individuals with OCD aged 5 and older, including adults and children, addressing a documented 14-17 year average delay in diagnosis and a 70% misdiagnosis rate in traditional care.

In early 2025, NOCD achieved its first month of positive EBITDA and acquired Rebound Health, a Prolonged Exposure-based PTSD treatment platform. Both brands were restructured under a newly created parent company called Noto, described as an AI-enabled platform designed to scale specialty mental health care. NOCD has raised approximately $84 million since 2018 from investors including F-Prime Capital (Series B lead), 7wireVentures, Cigna Ventures, Kaiser Permanente Ventures, Eight Roads Ventures, Health Enterprise Partners, and Longitude Capital, reaching a valuation of nearly $270 million in 2024.

NOCD firmographics

Firmographics
Name
NOCD
Legal name
NOCD Inc.
Website
https://treatmyocd.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
501–1,000 employees
Short description
NOCD is the world's largest dedicated telehealth provider of OCD treatment, delivering evidence-based ERP therapy via live video to patients across all 50 US states, Canada, the UK, and Australia, with revenue intermediated through 70+ insurance plans covering 137 million commercial lives.
Ownership category
akta.pro rank

NOCD industry classification

Industry
Product category
OCD Telehealth Therapy
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLALAEAJ
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAFACAJ
Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP)
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

Keywords

  • OCD telehealth therapy
  • Behavioral health platform
  • ERP therapy services
  • Online mental health
  • Exposure response prevention

Where NOCD is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

NOCD business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Insurance-Covered Telehealth Therapy: NOCD bills insurance plans directly for therapy sessions. The company accepts 70+ health plans including major insurers like Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield. Members pay copays as determined by their insurance coverage.
  2. Out-of-Pocket / Cash Pay: For patients without adequate insurance coverage or seeking services not covered by insurance (such as the Intensive Treatment Program), NOCD offers out-of-pocket payment options with interest-free payment plans available.
  3. Intensive Treatment Program: The Intensive Treatment Program costs $7,400 for the first three weeks, with weekly billing continuing for the remainder of the six-week program. An admission assessment costs $240 and is billed separately.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStandard Insurance-Covered ERP Therapy
One time/ perpetual licensePay-as-you-goIntensive Treatment Program - First 3 Weeks
Unit PricingPay-as-you-goIntensive Treatment Program - Weeks 4-6

Go-to-market motion1 record

Distribution channels3 records

Marketing channels12 records

NOCD product offering

Product offering

Core offering

NOCD operates an online behavioral health treatment platform that delivers specialized ERP (Exposure and Response Prevention) therapy for OCD via live, face-to-face video teletherapy sessions with licensed therapists trained in OCD treatment. The core offering is NOCD Therapy, consisting of twice-weekly 60-minute remote ERP video sessions for three weeks followed by once-weekly 30-minute check-ins, supported by 24/7 mobile app access including therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. NOCD also offers a 3-6 week virtual Intensive Treatment Program for severe cases priced at $7,400 for the first three weeks.

Product overview

NOCD operates a telehealth platform centered on OCD treatment, combining live video ERP therapy with a mobile app for between-session support. The core offerings include NOCD Therapy (live video sessions with specialized therapists), the NOCD App (support tools, ERP exercises, and peer community), NOCD Academy (continuing education for providers), and an Intensive Treatment Program (virtual IOP for severe cases). In March 2025, NOCD acquired Rebound Health and created parent company Noto to expand into PTSD treatment and broader behavioral health conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • Rebound Health: Trauma recovery platform using Prolonged Exposure principles for PTSD treatment, operating as the second brand under Noto parent company.
  • Noto

Products and services

  • NOCD Therapy NOCD Therapy is a telehealth OCD treatment service delivering live, face-to-face video ERP (Exposure and Response Prevention) therapy sessions with specialty-trained licensed therapists. The standard treatment protocol includes twice-weekly 60-minute remote ERP video sessions for three weeks, followed by once-weekly 30-minute video check-in sessions, supported by 24/7 mobile app access to therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. Therapy is covered by 70+ health plans including Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield, with patients paying applicable copays. For uninsured or underinsured patients, out-of-pocket payment options with interest-free payment plans are available. The service targets individuals with OCD (adults and children ages 5+) seeking evidence-based specialty care.
  • Intensive Treatment Program The Intensive Treatment Program is a 3-6 week virtual intensive outpatient program (IOP) that combines daily group and individual therapy using ERP and CBT for adults with severe OCD who need more immersive support than standard weekly therapy. The program is priced at $7,400 for the first three weeks, with weekly billing continuing for the remainder of the 3-6 week program based on clinical need. An admission assessment costs $240 and is billed separately. The Intensive Treatment Program can lead to up to 47% symptom reduction.

Quantifiable outcome

  • 43.4% mean reduction in OCD symptoms
  • +11 more outcomes

Companies that use NOCD

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

NOCD technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

NOCD partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • Rebound HealthcoreStrategic or Co-development Partner · 27 January 2026NOCD acquired Rebound Health, a trauma recovery platform using Prolonged Exposure principles for PTSD treatment. Rebound operates as the second brand under Noto, NOCD's AI-enabled parent platform. The acquisition expanded NOCD into PTSD treatment and added over 100 PE-trained specialists to its network.
  • Kaiser PermanentecoreChannel Partner/ Reseller/ DistributorKaiser Permanente is a key insurance partner, with NOCD accepting Kaiser plans including Northern and Southern California regions. Kaiser Permanente Ventures also invested in NOCD.
  • AetnacoreChannel Partner/ Reseller/ DistributorAetna is a major in-network insurance partner, with NOCD accepting Aetna plans across its network of therapists.
  • CignacoreChannel Partner/ Reseller/ DistributorCigna is an in-network insurance partner for NOCD therapy services, with Cigna Ventures also providing investment.
  • Blue Cross Blue ShieldcoreChannel Partner/ Reseller/ DistributorBlue Cross Blue Shield (BCBS) is an in-network insurance partner across multiple state plans including Illinois, Rhode Island, Massachusetts, Michigan, and Virginia.
  • United Healthcare / OptumcoreChannel Partner/ Reseller/ DistributorUnited Healthcare and Optum are in-network insurance partners providing coverage for NOCD therapy services.

Scale indicators12 records

Recent moves3 records

Expansion highlights6 records

NOCD competitors and assessment

Company assessment

Direct peers

  • Brightside Health: Telehealth mental health platform providing evidence-based therapy and medication management for depression, anxiety, and related conditions. Direct peer in virtual specialty behavioral health delivery with similar insurance-billed model and outcomes-focused positioning.
  • Cerebral: Subscription-based telehealth platform focused on anxiety, depression, ADHD, and related conditions, with combined therapy and medication management. Direct competitor in insurance-billed virtual mental health for similar patient demographics.
  • Talkiatry: Psychiatry-focused telehealth platform offering in-network medication management and therapy for conditions including anxiety, OCD, and PTSD. Direct peer in specialty virtual psychiatry with similar insurance-billed model and clinical-outcome orientation.

Broad incumbents

  • Talkspace: Public online therapy platform offering text/video sessions with licensed therapists across mental health conditions. Competes for the same insured patient population and payer contracts but serves a much broader condition set with less specialization.
  • BetterHelp: Largest consumer online therapy marketplace (owned by Teladoc). Competes broadly in virtual therapy delivery, including for OCD patients, though with a generalist therapist network rather than OCD specialization.
  • Lyra Health: Enterprise mental health benefits provider serving large employers with a blended in-person and virtual provider network. Competes for payer and employer contracts and offers specialty care routing, including for anxiety and OCD.

Emerging players

  • Spring Health: Employer-sponsored mental health benefits platform with personalized care routing across therapy, coaching, and medication. Competes for the same B2B payer channel and increasingly offers specialty care pathways that could include OCD-specific programs.
  • Headway: Insurance-network and billing platform that helps therapists go in-network with major payers. Functions as both an enabler for NOCD's therapist network and a potential competitor building its own patient-facing therapy marketplace.
  • Alma: Therapist network platform providing insurance billing, credentialing, and referrals. Comparable in building a scaled, insurance-friendly therapist network with similar payer relationships, though with a broader condition focus than NOCD.
  • Two Chairs: Therapy platform operating hybrid in-person and virtual clinics with a matched-care model emphasizing therapist-client fit. Competes for in-network insured patients seeking specialized therapy, including anxiety and OCD.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

NOCD social profiles

Digital presence

NOCD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NOCD leadership team

Management profile

Number of profiles

Profiles14 records

NOCD subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

NOCD funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NOCD M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NOCD

What does NOCD do?

NOCD operates an online behavioral health treatment platform that delivers specialized ERP (Exposure and Response Prevention) therapy for OCD via live, face-to-face video teletherapy sessions with licensed therapists trained in OCD treatment. The core offering is NOCD Therapy, consisting of twice-weekly 60-minute remote ERP video sessions for three weeks followed by once-weekly 30-minute check-ins, supported by 24/7 mobile app access including therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. NOCD also offers a 3-6 week virtual Intensive Treatment Program for severe cases priced at $7,400 for the first three weeks.

Is NOCD a public or private company?

NOCD is a private company. It is classified as venture growth investor backed and is currently operating.

When was NOCD founded?

NOCD was founded in 2015. It employs 501 to 1,000 people.

Where is NOCD based?

NOCD is headquartered in Chicago, United States, in the North America region.

How does NOCD make money?

Three revenue lines are on record. Insurance-Covered Telehealth Therapy is the primary driver. The others are out-of-Pocket / Cash Pay and intensive Treatment Program.

Who are NOCD's main competitors?

Direct peers on record are Brightside Health, Cerebral and Talkiatry. Broad incumbents are Talkspace, BetterHelp and Lyra Health. Emerging players are Spring Health, Headway, Alma and Two Chairs.

Does NOCD have an API?

No public API is recorded for NOCD.

What industry is NOCD in?

NOCD's product category is OCD Telehealth Therapy. Its primary akta.pro industry code is HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching), with a secondary code of HLAFACAJ, Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP). Its NAICS code is 621420 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooHowie Mandel Says OCD Has Cost Him Flights, Meetings and ‘Life’ as Rainn Wilson Calls It a ‘Hijacking of the Brain’Howie Mandel and Rainn Wilson discussed their obsessive-compulsive disorder experiences in a NOCD podcast preview, with Mandel saying it cost him flights and meetings. Wilson described it as a 'hijacking of the brain' and credited exposure and response prevention therapy for helping him. The full conversation premieres Oct. 11.Bhbusiness5 Behavioral Health VC Investors to WatchVC funding in behavioral health rebounded in 2026 after a 2024 low, with large rounds like Talkiatry's $210M Series D and Grow Therapy's $150M Series D. The article highlights five firms—GreyMatter, Goldman Sachs Alternatives, Kaiser, General Catalyst, and HealthQuest—backing tech-enabled providers and specialized services.MedCity NewsNOCD Announces Plans for National Expansion of Intensive Outpatient TherapyNOCD announced plans to expand its virtual intensive outpatient program for obsessive-compulsive disorder from a limited regional footprint to a national scale. The program, part of parent company Noto, currently operates in four states with waitlists in six others and aims to address the historical lack of accessible, specialty OCD care. Expansion is driven by partnerships with health plans to broaden insurance coverage as the company seeks to prove this treatment model.Business Wire BlogNOCD Commits to Nationwide Access to Intensive Outpatient Therapy; Names Leadership Team to Scale Its Virtual ProgramNOCD, the world's largest virtual specialty therapy company for OCD, announced its commitment to making intensive outpatient therapy available nationwide through its virtual IOP program powered by the Noto AI-enabled platform. The company named a leadership team including David Cohn as General Manager and several clinical leaders to scale the program, which currently serves members in Colorado, Montana, Michigan, and Texas with waitlists open in six additional states. The program offers structured ERP treatment combining group and individual sessions, extending NOCD's care continuum beyond its outpatient model to serve patients requiring higher levels of OCD care.B2B SaaS Blogtreatmyocd.com Revenue 2025: $201.3M ARRtreatmyocd.com reported $201.3M in revenue for 2025, with 612 employees as of September 2025. The company, led by CEO Armaan Mehta, provides online OCD treatment and telehealth services. No funding information is disclosed.Bhbusiness5 Mental Health Companies to Watch in 2026 and BeyondFive mental health companies are highlighted for 2026: Discovery Behavioral Health, Salma Health, UHS, NOCD, and Hazel Health. Discovery was taken over by creditors after defaulting on $280 million in debt, while Salma raised $80 million for interventional psychiatry. UHS plans to acquire Talkspace for $835 million.FortuneHowie Mandel made a panic attack a mental health movement and helped build a company worth millionsNOCD, a virtual therapy company specializing in OCD treatment co-founded by Stephen Smith, has grown into the largest telehealth provider in this space with a valuation of nearly $270 million in 2024. Howie Mandel, who publicly shared his OCD diagnosis after an accidental confession on Howard Stern's show, has become the company's public face and advocates for mental health awareness. The company recently acquired Rebound Health and launched a parent brand called Noto, expanding its services to include PTSD treatment while providing over a million therapy sessions annually to patients with insurance access.BhbusinessThe Case for Going Niche in Behavioral HealthThis BHB+ opinion piece argues that new behavioral health providers should start with specific, narrow conditions rather than broad mental health services. The article cites NOCD as a leading example—a startup launched in 2018 focused exclusively on obsessive-compulsive disorder that raised approximately $84 million from investors including Cigna Ventures, 7wireVentures, Kaiser Permanente Ventures, and F-Prime Capital, and achieved its first month of positive EBITDA before expanding. In March 2025, NOCD announced the acquisition of trauma care provider Rebound Health and simultaneously restructured both companies under a new parent company called Noto, positioning itself as a specialty behavioral health provider for complex psychiatric conditions.ModernhealthcareHealth tech company CEOs dish on recent acquisitionsHealth tech M&A activity accelerated in early 2026, with five deals announced in the span of two weeks, continuing a trend that began in 2025. Spring Health pursued acquisitions specifically to gain access to established payer relationships, while NOCD achieved cash-flow positivity for the first time in 2025, which provided the financial foundation for its own acquisition. The article features CEOs discussing these recent transactions, though specific details about deal values or acquired targets are not provided.MedCity NewsNOCD Launches Parent Brand Noto, Acquires PTSD Provider Rebound HealthNOCD launched its parent brand Noto and acquired Rebound Health, a PTSD provider, to expand into other virtual therapies. Noto provides AI-powered payer and clinical support, while Rebound will operate as a dedicated specialty under Noto. The company plans to expand into additional specialties in the future.